A Tale of Two Cities – Lagos, Nigeria’s Apparent Success in the War Against COVID-19 (Crossover Prophylaxis Against Coronavirus by Antimalarial Agents)
13 Pages Posted: 22 Jun 2020
Date Written: June 16, 2020
A person’s chances of dying from the coronavirus in this 2020 COVID-19 pandemic are more than six hundred times greater in New York City than in Lagos, Nigeria. This fact, at least this specific comparison, does not seem to be previously reported in the medical literature. It certainly is not emphasized. This dramatic disparity contradicts or at least diminishes the conventional wisdom that coronavirus mortality is exacerbated by city life, specifically poverty, overcrowding, racial differences, and diminished access to health care. The dramatic disparity in fatality rates between these two cities flies in the face of our traditional understanding of the social determinants of health. There is clearly a different factor at play here. These facts demand an explanation. This apparent protective effect conferred on those living in Lagos compared to New York City should be further analyzed for its etiology, significance, and potential benefit to others.
Note: Funding: There was no funding for this paper.
Conflict of Interest: The author declares that he has no competing interests.
Keywords: coronavirus, COVID-19, mortality, fatality, disparity, New York City, NYC, Lagos, Nigeria, antimalarial, racial, poverty, overcrowding, protective, pharmacology, prophylaxis, crossover, epidemiology, quinoline, atovaquone, mefloquine, chloroquine
Suggested Citation: Suggested Citation